unknown
Stage
1
Investors
About
Galera Therapeutics, Inc. is a clinical-stage biotechnology company developing novel therapeutics to improve cancer treatment, focusing on reducing radiation-induced severe oral mucositis and enhancing radiotherapy efficacy.
Explore Galera Therapeutics, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.